Xenon Gas Treatment Studied at Turku University Hospital Progresses into Drug Development
Xenon gas was studied at the Intensive Care Unit (ICU) of Turku University Hospital, Finland in 2009–2014 as a treatment for minimising the damage of cardiac arrest, and now it enters drug development in spring 2018. NeuroproteXeon is advancing the study of xenon in a pivotal phase III trial. An earlier study discovered that xenon protects the white matter in the brain from damage and the latest research showed that xenon can also protect the heart.